[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337508-105":59,"doc-detail-337508-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","boolean-modeling-of-breast-cancer-signaling-pathways-uncovers-mechanisms-of-drug-synergy-research-article","Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy - Research Article","","Boolean modeling of breast cancer signaling pathways is developed to identify how drug combinations produce synergy. The model integrates cell-line specific mutations, gene expression, and drug treatments to represent five breast cancer cell lines and reproduce protein activities and drug-response behaviors consistent with experiments. Protein synergy scores (PSSs) quantify combination effects on individual proteins, enabling evaluation of synergy across 150 drug combinations and clustering drug pairs into five synergy modes linked to distinct protein activity patterns.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/boolean-modeling-of-breast-cancer-signaling-pathways-uncovers-mechanisms-of-drug-synergy-research-article/337508/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/boolean-modeling-of-breast-cancer-signaling-pathways-uncovers-mechanisms-of-drug-synergy-research-article/337508.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",15,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main goal of the study?","Question",{"text":113,"@type":114},"To build a Boolean model of breast cancer signaling pathways that explains and predicts mechanisms of drug synergy.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the model represent different breast cancer cell lines?",{"text":118,"@type":114},"It integrates cell-line specific mutations, gene expression, and drug treatments to tailor pathway behavior to five cancer cell lines.",{"name":120,"@type":111,"acceptedAnswer":121},"What are protein synergy scores (PSSs) used for?",{"text":122,"@type":114},"PSSs quantify how drug combinations affect individual protein activities, supporting identification of synergistic effects and downstream clustering.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337508,1790513909,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","PLOS ONE  \nOPEN ACCESS  \nCitation: Taoma K, Ruengjitchatchawalya M, Liangruksa M, Laomettachit T (2024) Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy. PLoS ONE 19(2): e0298788 . [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0298788  \nEditor: Aniruddha Datta, Texas A&M University, UNITED STATES  \nReceived: September 25, 2023  \nAccepted: January 30, 2024  \nPublished: February 23, 2024  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here:  \n[https://doi.org/10.1371/journal.pone.0298788](https://doi.org/10.1371/journal.pone.0298788)  \n[Copyright:](Copyright:) © [2024 Taoma et al](2024 Taoma et al). This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: All relevant data are within the manuscript and its Supporting information files. The programming script and related data required to reproduce the simulations  \nRESEARCH ARTICLE  \nBoolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy  \nKittisak Taoma1,2, Marasri Ruengjitchatchawalya1,3, Monrudee Liangruksa4 *, Teeraphan Laomettachit1,5 *  \n1 Bioinformatics and Systems Biology Program, School of Bioresources and Technology, King Mongkut’s University of Technology Thonburi, Bangkok, Thailand, 2 School of Information Technology, King Mongkut’s University of Technology Thonburi, Bangkok, Thailand, 3 Biotechnology Program, School of Bioresources and Technology, King Mongkut’s University of Technology Thonburi, Bangkok, Thailand, 4 National Nanotechnology Center, National Science and Technology Development Agency (NSTDA), Pathum Thani, Thailand, 5 Theoretical and Computational Physics Group, Center of Excellence in Theoretical and Computational Science, King Mongkut’s University of Technology Thonburi, Bangkok, Thailand  \n* [monrudee@nanotec.or.th](monrudee@nanotec.or.th) (ML); [teeraphan.lao@kmutt.ac.th](teeraphan.lao@kmutt.ac.th) (TL)  \nAbstract  \nBreast cancer is one of the most common types of cancer in females. While drug combinations have shown potential in breast cancer treatments, identifying new effective drug pairs is challenging due to the vast number of possible combinations among available compounds. Efforts have been made to accelerate the process with in silico predictions. Here, we developed a Boolean model of signaling pathways in breast cancer. The model was tailored to represent five breast cancer cell lines by integrating information about cell-line specific mutations, gene expression, and drug treatments. The models reproduced cell-line specific protein activities and drug-response behaviors in agreement with experimental data. Next, we proposed a calculation of protein synergy scores (PSSs), determining the effect of drug combinations on individual proteins’ activities. The PSSs of selected proteins were used to investigate the synergistic effects of 150 drug combinations across five cancer cell lines. The comparison of the highest single agent (HSA) synergy scores between experiments and model predictions from the MDA-MB-231 cell line achieved the highest Pearson’s correlation coefficient of 0.58 with a great balance among the classification metrics (AUC = 0.74, sensitivity = 0.63, and specificity = 0.64) . Finally, we clustered drug pairs into groups based on the selected PSSs to gain further insights into the mechanisms underlying the observed synergistic effects of drug pairs. Clustering analysis allowed us to identify distinct patterns in the protein activities that correspond to five different modes of synergy: 1) synergis","cbCailRVpcNfFfei","https://ap.wps.com/l/cbCailRVpcNfFfei","pdf",4620249,24,"English","# Abstract\n## Methods (Boolean modeling and PSS calculation)\n## Validation and comparison to experiments\n## Clustering and synergy mode interpretation","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To build a Boolean model of breast cancer signaling pathways that explains and predicts mechanisms of drug synergy.\"},{\"question\":\"How does the model represent different breast cancer cell lines?\",\"answer\":\"It integrates cell-line specific mutations, gene expression, and drug treatments to tailor pathway behavior to five cancer cell lines.\"},{\"question\":\"What are protein synergy scores (PSSs) used for?\",\"answer\":\"PSSs quantify how drug combinations affect individual protein activities, supporting identification of synergistic effects and downstream clustering.\"}]","Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy - Research Article | PDF",1790019365,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/308202b7c8be515508f2d47a86b3d301.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a564107d1a535e18e0ad7eb6a9568a62.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1cd55d5ab5434d5df7ae087bdced6393.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/065abeff36cbfa456db749b94493ab35.webp",980,1268]